SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-020248
Filing Date
2021-03-12
Accepted
2021-03-12 17:37:14
Documents
1
Period of Report
2021-01-15

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4326
  Complete submission text file 0001209191-21-020248.txt   5690
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CRISPR THERAPEUTICS AG 610 MAIN STREET 7TH FLOOR CAMBRIDGE MA 02139
Business Address
Klein Lawrence Otto (Reporting) CIK: 0001762583 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37923 | Film No.: 21738754